137 related articles for article (PubMed ID: 10922339)
1. Risk factors for benign proliferative breast disease.
Friedenreich C; Bryant H; Alexander F; Hugh J; Danyluk J; Page D
Int J Epidemiol; 2000 Aug; 29(4):637-44. PubMed ID: 10922339
[TBL] [Abstract][Full Text] [Related]
2. Benign proliferative breast diseases among female patients at a sub-Saharan Africa tertiary hospital: a cross sectional study.
Okoth C; Galukande M; Jombwe J; Wamala D
BMC Surg; 2013 Apr; 13():9. PubMed ID: 23548039
[TBL] [Abstract][Full Text] [Related]
3. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
[TBL] [Abstract][Full Text] [Related]
4. Effects of mammographic density and benign breast disease on breast cancer risk (United States).
Byrne C; Schairer C; Brinton LA; Wolfe J; Parekh N; Salane M; Carter C; Hoover R
Cancer Causes Control; 2001 Feb; 12(2):103-10. PubMed ID: 11246838
[TBL] [Abstract][Full Text] [Related]
5. Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Aaman TB; Stalsberg H; Thomas DB
Int J Cancer; 1997 May; 71(3):333-9. PubMed ID: 9139863
[TBL] [Abstract][Full Text] [Related]
6. Benign breast disease, mammographic breast density, and the risk of breast cancer.
Tice JA; O'Meara ES; Weaver DL; Vachon C; Ballard-Barbash R; Kerlikowske K
J Natl Cancer Inst; 2013 Jul; 105(14):1043-9. PubMed ID: 23744877
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for benign breast biopsies: a nested case-control study in the Alberta breast screening program.
Friedenreich CM; Bryant HE; Alexander F; Hugh J; Danyluk J; Page DL
Cancer Detect Prev; 2001; 25(3):280-91. PubMed ID: 11425270
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of benign breast disease and the risk of breast cancer.
London SJ; Connolly JL; Schnitt SJ; Colditz GA
JAMA; 1992 Feb; 267(7):941-4. PubMed ID: 1734106
[TBL] [Abstract][Full Text] [Related]
9. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.
Kabat GC; Jones JG; Olson N; Negassa A; Duggan C; Ginsberg M; Kandel RA; Glass AG; Rohan TE
Cancer Causes Control; 2010 Jun; 21(6):821-8. PubMed ID: 20084540
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.
Castells X; Domingo L; Corominas JM; Torá-Rocamora I; Quintana MJ; Baré M; Vidal C; Natal C; Sánchez M; Saladié F; Ferrer J; Vernet M; Servitja S; Rodríguez-Arana A; Roman M; Espinàs JA; Sala M
Breast Cancer Res Treat; 2015 Jan; 149(1):237-44. PubMed ID: 25503778
[TBL] [Abstract][Full Text] [Related]
11. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
[TBL] [Abstract][Full Text] [Related]
12. A pathologic study of benign breast diseases in Tokyo and New York.
Schuerch C; Rosen PP; Hirota T; Itabashi M; Yamamoto H; Kinne DW; Beattie EJ
Cancer; 1982 Nov; 50(9):1899-903. PubMed ID: 7116314
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
Visscher DW; Frank RD; Carter JM; Vierkant RA; Winham SJ; Heinzen EP; Broderick BT; Denison LA; Allers TM; Johnson JL; Frost MH; Hartmann LC; Degnim AC; Radisky DC
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28376198
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
Dupont WD; Parl FF; Hartmann WH; Brinton LA; Winfield AC; Worrell JA; Schuyler PA; Plummer WD
Cancer; 1993 Feb; 71(4):1258-65. PubMed ID: 8435803
[TBL] [Abstract][Full Text] [Related]
15. Benign breast biopsy diagnosis and subsequent risk of breast cancer.
Ashbeck EL; Rosenberg RD; Stauber PM; Key CR
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):467-72. PubMed ID: 17337650
[TBL] [Abstract][Full Text] [Related]
16. Benign breast disease and cancer risk.
Bianchi S; Palli D; Galli M; Zampi G
Crit Rev Oncol Hematol; 1993 Dec; 15(3):221-42. PubMed ID: 8142058
[No Abstract] [Full Text] [Related]
17. Methylxanthines and benign breast disease.
Schairer C; Brinton LA; Hoover RN
Am J Epidemiol; 1986 Oct; 124(4):603-11. PubMed ID: 3752054
[TBL] [Abstract][Full Text] [Related]
18. Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease.
Catsburg C; Gunter MJ; Chen C; Cote ML; Kabat GC; Nassir R; Tinker L; Wactawski-Wende J; Page DL; Rohan TE
Cancer Res; 2014 Jun; 74(12):3248-58. PubMed ID: 24755474
[TBL] [Abstract][Full Text] [Related]
19. Sclerosing adenosis and risk of breast cancer.
Visscher DW; Nassar A; Degnim AC; Frost MH; Vierkant RA; Frank RD; Tarabishy Y; Radisky DC; Hartmann LC
Breast Cancer Res Treat; 2014 Feb; 144(1):205-12. PubMed ID: 24510013
[TBL] [Abstract][Full Text] [Related]
20. Extra-tumoral breast tissue in breast-cancer patients: variations with a family history of breast cancer. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Aaman TB; Stalsberg H; Thomas DB
Int J Cancer; 1998 Feb; 79(1):39-43. PubMed ID: 9495356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
